Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000131.xml
Synfacts 2020; 16(06): 0619
DOI: 10.1055/s-0040-1707529
DOI: 10.1055/s-0040-1707529
Synthesis of Natural Products and Potential Drugs
Synthesis of Monobactam Antibiotic LYS228
Further Information
Publication History
Publication Date:
15 May 2020 (online)
Key words
LYS228 - monobactam antibiotic - asymmetric synthesis - [2+2] cycloaddition - Staudinger β-lactam synthesisSignificance
LYS228 is a monobactam antibiotic that inhibits cell-wall synthesis in Gram-negative bacteria through covalent modification of the active-site serine of penicillin-binding protein 3. It is active in vitro and in vivo against Enterobacteriaceae, and it is stable to most serine-β-lactamases and all metallo-β-lactamases profiled to date.
#
Comment
The key step in the manufacturing process for LYS228 depicted is the asymmetric Staudinger β-lactam synthesis involving a [2+2] cycloaddition of a ketene derived from C with aldimine B derived from (S)-glyceraldehyde acetonide A (C. Hubschwerlen, J.-L. Specklin Org. Synth. 1995, 72, 14). For the discovery synthesis, see: Bioorg. Med. Chem. Lett. 2018, 28, 7748.
#
#